Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
A Pilot Clinical Study to Evidence Improved Cranial Flap Fixation with a Bioresorbable Bone Adhesive
- Conditions
- Craniotomy
- First Posted Date
- 2025-01-17
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- RevBio
- Target Recruit Count
- 15
- Registration Number
- NCT06780852
- Locations
- 🇬🇧
Bristol Southmead Hospital, Bristol, United Kingdom
A Pilot Study to Evidence Improved Cranial Flap Fixation With a Bioresorbable Bone Adhesive
- Conditions
- Craniotomy
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2025-07-09
- Lead Sponsor
- RevBio
- Target Recruit Count
- 20
- Registration Number
- NCT06095531
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Semmes Murphey Clinic, Memphis, Tennessee, United States
Feasibility Study to Assess Outcomes of Immediately Inserted and Restored Dental Implants Using pH-modified Tetranite
- Conditions
- Adhesive Dental
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2022-10-26
- Lead Sponsor
- RevBio
- Target Recruit Count
- 15
- Registration Number
- NCT05535426
- Locations
- 🇬🇧
Norton Implants, London, United Kingdom
Immediate Placement and Stabilization of Dental Implants With Tetranite Stabilization Material in Mandibular and Maxillary Tooth Extraction Sites That Fail to Provide Adequate Primary Stability
- Conditions
- Adhesive Dental
- First Posted Date
- 2019-10-09
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- RevBio
- Target Recruit Count
- 20
- Registration Number
- NCT04121364
- Locations
- 🇺🇸
University of Texas Health Science Center - San Antonio, San Antonio, Texas, United States
News
RevBio Secures $2.2 Million NIH Grant to Advance TETRANITE Bone Adhesive for Vertebral Fracture Treatment
RevBio received a $2.2 million Phase II SBIR grant from the National Institute on Aging to advance preclinical testing of TETRANITE, a synthetic bone adhesive for treating vertebral compression fractures.
RevBio's Tetranite Bone Adhesive Trial Expanded Following FDA Nod, Gains CMS Reimbursement
RevBio received FDA approval to expand its clinical trial for Tetranite, a bone adhesive biomaterial, after demonstrating safety in initial patients.